Primary staging and follow-up of high risk melanoma patients with whole-body 18F-fluorodeoxyglucose positron emission tomography: results of a prospective study of 100 patients

Cancer. 1999 Mar 1;85(5):1199-201. doi: 10.1002/(sici)1097-0142(19990301)85:5<1199::aid-cncr28>3.0.co;2-1.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Fluorodeoxyglucose F18*
  • Follow-Up Studies
  • Humans
  • Lymphatic Metastasis / diagnostic imaging
  • Melanoma / diagnostic imaging*
  • Neoplasm Staging
  • Prospective Studies
  • Radiopharmaceuticals*
  • Risk
  • Skin Neoplasms / diagnostic imaging*
  • Tomography, Emission-Computed / methods*

Substances

  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18